192 related articles for article (PubMed ID: 15484265)
1. Change in hepatitis C virus genotype in injecting drug users.
Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M
J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
[TBL] [Abstract][Full Text] [Related]
3. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
4. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily.
Vitale F; Villafrate MR; Viviano E; Perna AM; Bonura F; Di Benedetto MA; Mazzola G; Colletti P; Prestileo T; Romano N
New Microbiol; 1998 Oct; 21(4):335-42. PubMed ID: 9812314
[TBL] [Abstract][Full Text] [Related]
5. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
Bowden S; McCaw R; White PA; Crofts N; Aitken CK
J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
[TBL] [Abstract][Full Text] [Related]
6. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
7. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
8. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
9. [Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].
Krekulová L; Rehák V; Strunecký O; Nēmecek V
Epidemiol Mikrobiol Imunol; 2009 Apr; 58(2):84-9. PubMed ID: 19526922
[TBL] [Abstract][Full Text] [Related]
10. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
Micalessi MI; Gérard C; Ameye L; Plasschaert S; Brochier B; Vranckx R
J Med Virol; 2008 Apr; 80(4):640-5. PubMed ID: 18297717
[TBL] [Abstract][Full Text] [Related]
11. Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started.
Sereno S; Perinelli P; Laghi V
J Clin Virol; 2009 Aug; 45(4):354-7. PubMed ID: 19497783
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
[TBL] [Abstract][Full Text] [Related]
13. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
[TBL] [Abstract][Full Text] [Related]
14. Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.
Buckton AJ; Ngui SL; Arnold C; Boast K; Kovacs J; Klapper PE; Patel B; Ibrahim I; Rangarajan S; Ramsay ME; Teo CG
J Clin Microbiol; 2006 Aug; 44(8):2779-84. PubMed ID: 16891492
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
[TBL] [Abstract][Full Text] [Related]
16. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
17. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
19. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
20. Pattern of hepatitis C virus genotypes in HIV infected patients in RIMS, Hospital, Imphal, Manipur.
Pukhrambam PD; Singh NB; Singh LH; Devi KhS
J Commun Dis; 2007 Mar; 39(1):21-4. PubMed ID: 18338712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
